Botanix Pharmaceuticals Limited (AU:BOT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Botanix Pharmaceuticals Ltd has announced the issuance of 36 million performance rights under an employee incentive scheme, which are not intended for public trading on the ASX. This move could signify strategic efforts to motivate and retain key employees as the company advances its business objectives.
For further insights into AU:BOT stock, check out TipRanks’ Stock Analysis page.